短期机械循环支持桥接持久性左心室辅助装置治疗难治性心源性休克
该回顾性研究纳入2004至2014年间382例连续流左心室辅助装置植入患者,其中45例(12%)因难治性心源性休克先用短期机械循环支持桥接。桥接后院内死亡率为18%,右心室辅助装置使用率达27%,术后使用右心室辅助装置是全队列总体死亡的显著预测因素。
要点
- 短期机械循环支持可改善难治性心源性休克患者的终末器官功能与血流动力学,作为桥接策略可行。
- 桥接后植入持久性左心室辅助装置的院内死亡率为18%,右心室辅助装置使用率高达27%。
- 术后使用右心室辅助装置是总体死亡的显著预测因素,而短期机械循环支持本身不是。
核心结论
- 短期机械循环支持可优化难治性心源性休克患者并作为持久性左心室辅助装置植入的桥接,但植入后早期死亡率高,原因在于未被识别的右心室衰竭。
研究设计与样本
- 回顾性研究,纳入2004至2014年间382例接受连续流左心室辅助装置植入的患者,其中45例(12%)以短期机械循环支持桥接。
- 桥接队列平均年龄53±10岁,87%为男性;初始支持类型包括经皮装置24例(53%)和体外连续流心室辅助装置21例(47%)。
- 短期机械循环支持中位持续时间为14.0天(四分位距7.5-29.5天)。
- 采用多因素Cox比例风险模型评估全队列总体死亡的预测因素。
主要发现
- 短期机械循环支持显著改善终末器官功能与血流动力学。
- 转为持久性左心室辅助装置植入后,院内死亡率为18%。
- 右心室辅助装置使用率高达27%。
- 总体生存率1年为70%,2年为62%。
- 全队列Cox多因素分析显示术后使用右心室辅助装置是总体死亡的显著预测因素(风险比4.04;P<.001;95%CI 1.97-7.94),而使用短期机械循环支持不是(P=.937)。
临床怎么用
- 对难治性心源性休克患者可考虑以短期机械循环支持桥接持久性左心室辅助装置植入。
- 桥接后需警惕未被识别的右心室衰竭,术后右心室辅助装置使用与总体死亡风险显著升高相关。
局限性
- 回顾性研究设计。
- 桥接队列样本量较小(45例)。
- 单中心数据,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The role of short-term mechanical circulatory support has increased in patients with refractory cardiogenic shock. However, limited data exist on the outcomes of a bridge to a durable left ventricular assist device strategy using short-term mechanical circulatory support. METHODS: We retrospectively reviewed 382 patients who underwent continuous-flow left ventricular assist device insertion between 2004 and 2014. Of these, 45 (12%) were bridged with short-term mechanical circulatory support devices for refractory cardiogenic shock. We analyzed early and midterm outcomes in this bridged cohort. Multivariate Cox proportional hazards modeling was performed to evaluate the predictor of overall death in the entire cohort. RESULTS: The mean age of the bridged cohort was 53 ± 10 years, and 87% were male. The types of initial support included percutaneous devices in 24 patients (53%) and external continuous-flow ventricular assist device in 21 patients (47%). The median duration of short-term mechanical circulatory support was 14.0 (interquartile range, 7.5-29.5) days. The short-term mechanical circulatory support significantly improved end-organ function and hemodynamics. After conversion to durable left ventricular assist device insertion, in-hospital mortality was 18%. The incidence of right ventricular assist device use was high at 27%. The overall survival was 70% and 62% at 1 and 2 years, respectively. Cox multivariate hazard analysis in the entire cohort demonstrated that the use of a postoperative right ventricular assist device was a significant predictor of overall death (hazard ratio, 4.04; P < .001; 95% confidence interval, 1.97-7.94), but the use of a short-term mechanical circulatory support was not (P = .937). CONCLUSIONS: Short-term mechanical circulatory support can optimize patients in refractory cardiogenic shock and serve as a bridge to implantation of a durable left ventricular assist device. However, the early mortality rate after durable left ventricular assist device implantation is high because of unrecognized right ventricular failure.
引用
- Yoshioka D, Takayama H, Garan AR, et al. Bridge to durable left ventricular assist device for refractory cardiogenic shock. J Thorac Cardiovasc Surg. 2016. PMID: 27988030. doi:10.1016/j.jtcvs.2016.10.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。